WHO Approves First Malaria Drug Specifically for Infants
Malaria remains a significant health concern globally. This new drug represents a major breakthrough, offering critical treatment options for children under five, who account for a disproportionate number of deaths.
Children under five account for more than two-thirds of malaria deaths. A new drug offers hope for this vulnerable group.